OCGN · Ocugen, Inc. · Executive Compensation
$1.06
+0.03 (+2.91%)
At close · Sep 18
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“After evaluating these conditions and management's plans, the Company has concluded that there is substantial doubt about the Company's ability to continue as a going concern within one year after the date these condensed consolidated financial statements are issued.”View the 10-Q filed Aug 6, 2026
Market Cap
$359.46M
Shares
339.11M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Shankar Musunuri | Ph.D., MBA Chief Executive Officer, Chairman and Co-Founder | $4,841,822 |
| Huma Qamar | M.D., MPH, CMI Chief Medical Officer | $2,888,481 |
| Arun Upadhyay | Chief Scientific Officer | $2,136,069 |
| Ramesh Ramachandran | CPA, MBA, CMA Chief Accounting Officer | $1,192,089 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Shankar Musunuri | Ph.D., MBA Chief Executive Officer, Chairman and Co-Founder | $1,941,539 |
| Huma Qamar | M.D., MPH, CMI Chief Medical Officer | $1,725,701 |
| Arun Upadhyay | Chief Scientific Officer | $870,869 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Shankar Musunuri | Ph.D., MBA Chief Executive Officer, Chairman and Co-Founder | $4,535,231 |
| Arun Upadhyay | Chief Scientific Officer | $1,384,076 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Shankar Musunuri | Ph.D., MBA Chairman of the Board and Chief Executive Officer | $8,141,351 |
| Sanjay Subramanian | Former Chief Financial Officer, Head of Corporate Development, and Corporate Secretary | $2,602,661 |
| Vijay Tammara | Vice President, Regulatory Operations | $1,307,585 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Shankar Musunuri | Ph.D., MBA Chairman of the Board and Chief Executive Officer | $1,552,178 |
| Sanjay Subramanian | Former Chief Financial Officer, Head of Corporate Development, and Corporate Secretary | $661,790 |
| Rasappa Arumugham | Former Chief Scientific Officer | $591,043 |
| Daniel Jorgensen | M.D., M.P.H., MBA Former Chief Medical Officer | $537,139 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Adam Gridley | Former President | $768,937 |
| Shankar Musunuri | Ph.D., MBA Chairman of the Board and Chief Executive Officer | $572,320 |
| Stephen Kennedy | Former Executive Vice President and Chief Operating Officer | $532,835 |
| Daniel Jorgensen | M.D., M.P.H., MBA Former Chief Medical Officer | $432,303 |
| Donald Haut | Former Chief Business Officer | $410,968 |
| Rasappa Arumugham | Former Chief Scientific Officer | $365,358 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Adam Gridley | Former President | $664,121 |
| Daniel Jorgensen | Chief Medical Officer | $474,545 |
| Stephen Kennedy | Former Executive Vice President and Chief Operating Officer | $466,031 |
| Shankar Musunuri | Chief Executive Officer | $431,000 |
| Rasappa Arumugham | Chief Scientific Officer | $418,795 |
| Donald Haut | Former Chief Business Officer | $417,851 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Ramesh Ramachandran | Chief Accounting Officer | Resigned | 2026-06-03 |
| Mohamed Genead, M.D., M.Sc. | Acting/Interim Chief Medical Officer | Appointed | 2026-05-14 |
| Rita Johnson-Greene | principal financial officer | Appointed | 2026-02-09 |
| Rita Johnson-Greene | Chief Financial Officer | Appointed | 2026-02-09 |
| Prabha Fernandes, Ph.D., FIDSA | member of the Board of Directors | Resigned | 2025-04-25 |
| Ramesh Ramachandran | principal accounting officer | Appointed | 2024-11-15 |
| Ramesh Ramachandran | principal financial officer | Appointed | 2024-11-15 |
| Michael Breininger | Interim Chief Accounting Officer and principal financial officer | Appointed | 2023-09-19 |
| Quan Vu | Chief Financial Officer/Chief Business Officer, and as principal financial officer and principal accounting officer | Terminated | 2023-08-15 |
| Jessica Crespo | Chief Accounting Officer and principal accounting officer | Resigned | 2023-03-10 |
| Quan Anh Vu | Chief Financial Officer/Chief Business Officer and Principal Financial Officer | Appointed | 2023-03-06 |